{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:26:39Z","timestamp":1792517199384,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Emerging evidence suggests that the vascular manifestations of MASLD differ substantially between men and women. We therefore hypothesized that the mechanisms, plaque phenotypes, and clinical implications of MASLD-related ASCVD are sex-specific.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In this narrative review, we searched PubMed\/MEDLINE for studies published up to April 2026 and synthesized current evidence regarding sex differences in MASLD-related atherosclerosis. Available data support a sex-specific vascular paradigm in MASLD. In men, MASLD is more strongly associated with calcified and obstructive coronary atherosclerosis. In contrast, women with MASLD more frequently exhibit non-calcified atherosclerotic phenotypes and functional vascular abnormalities (e.g., endothelial dysfunction, arterial stiffness, and coronary microvascular dysfunction). Importantly, despite lower coronary artery calcium (CAC) burden, women with MASLD experience a disproportionately greater risk of adverse cardiovascular events. Therefore, calcification-centered assessment may inadequately capture ASCVD risk in women with MASLD by failing to identify non-calcified plaque and functional vascular abnormalities. These sex differences are likely mediated by interacting pathobiological and socio-cultural factors, including sex hormones and menopausal transition, adipose tissue distribution, immune-metabolic and inflammatory profiles, genetic susceptibility, and gender influences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MASLD is associated with distinct sex-specific cardiovascular phenotypes that have important clinical implications for ASCVD risk assessment and prevention. Women with MASLD may develop clinically significant ASCVD despite lower CAC burden, supporting a sex- and menopause-aware approach to cardiovascular evaluation. In selected high-risk women, complementary use of multimodality imaging beyond CAC may improve risk stratification and facilitate earlier detection of clinically relevant cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13293-026-00952-3","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:34:49Z","timestamp":1783431289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sex differences in MASLD-related atherosclerosis: plaque phenotype, vascular dysfunction, and cardiovascular outcomes"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1645-9989","authenticated-orcid":false,"given":"Mohamad","family":"Jamalinia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-0931","authenticated-orcid":false,"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9886-0698","authenticated-orcid":false,"given":"Amedeo","family":"Lonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"7","key":"952_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMra2412865","volume":"393","author":"G Targher","year":"2025","unstructured":"Targher G, Valenti L, Byrne CD. Metabolic dysfunction-associated steatotic liver disease. N Engl J Med. 2025;393(7):683\u201398. https:\/\/doi.org\/10.1056\/NEJMra2412865.","journal-title":"N Engl J Med"},{"key":"952_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.19615","author":"H Tilg","year":"2025","unstructured":"Tilg H, Petta S, Stefan N, Targher G. Metabolic dysfunction-associated steatotic liver disease in adults: a review. JAMA. 2025. https:\/\/doi.org\/10.1001\/jama.2025.19615.","journal-title":"JAMA"},{"issue":"4","key":"952_CR3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691\u2013702. https:\/\/doi.org\/10.1136\/gutjnl-2023-330595.","journal-title":"Gut"},{"key":"952_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2024.100386","volume":"41","author":"AJ Sanyal","year":"2024","unstructured":"Sanyal AJ, Husain M, Diab C, Mangla KK, Shoeb A, Lingvay I, et al. Cardiovascular disease in patients with metabolic dysfunction-associated steatohepatitis compared with metabolic dysfunction-associated steatotic liver disease and other liver diseases: a systematic review. Am Heart J Plus. 2024;41:100386. https:\/\/doi.org\/10.1016\/j.ahjo.2024.100386.","journal-title":"Am Heart J Plus"},{"issue":"4","key":"952_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/apt.17617","volume":"58","author":"M Jamalinia","year":"2023","unstructured":"Jamalinia M, Zare F, Lankarani KB. Systematic review and meta-analysis: association between liver fibrosis and subclinical atherosclerosis in nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2023;58(4):384\u201394. https:\/\/doi.org\/10.1111\/apt.17617.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"952_CR6","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1111\/dom.16568","volume":"27","author":"M Jamalinia","year":"2025","unstructured":"Jamalinia M, Zare F, Mantovani A, Targher G, Lonardo A. Metabolic dysfunction-associated steatotic liver disease and sex-specific risk of fatal and non-fatal cardiovascular events: a meta-analysis. Diabetes Obes Metab. 2025;27(9):5171\u201381. https:\/\/doi.org\/10.1111\/dom.16568.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"952_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/apt.17869","volume":"59","author":"M Jamalinia","year":"2024","unstructured":"Jamalinia M, Zare F, Noorizadeh K, Bagheri Lankarani K. Systematic review with meta-analysis: steatosis severity and subclinical atherosclerosis in metabolic dysfunction-associated steatotic liver disease. Aliment Pharmacol Ther. 2024;59(4):445\u201358. https:\/\/doi.org\/10.1111\/apt.17869.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"952_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11892-024-01542-6","volume":"24","author":"Y Castillo-N\u00fa\u00f1ez","year":"2024","unstructured":"Castillo-N\u00fa\u00f1ez Y, Almeda-Valdes P, Gonz\u00e1lez-G\u00e1lvez G, Arechavaleta-Granell MdR. Metabolic dysfunction-associated steatotic liver disease and atherosclerosis. Curr Diab Rep. 2024;24(7):158\u201366. https:\/\/doi.org\/10.1007\/s11892-024-01542-6.","journal-title":"Curr Diab Rep"},{"issue":"4","key":"952_CR9","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s12325-025-03121-x","volume":"42","author":"K Bagheri Lankarani","year":"2025","unstructured":"Bagheri Lankarani K, Jamalinia M, Zare F, Heydari ST, Ardekani A, Lonardo A. Liver-kidney-metabolic health, sex, and menopause impact total scores and monovessel vs. multivessel coronary artery calcification. Adv Ther. 2025;42(4):1729\u201344. https:\/\/doi.org\/10.1007\/s12325-025-03121-x.","journal-title":"Adv Ther"},{"key":"952_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf1059","author":"O Manfrini","year":"2026","unstructured":"Manfrini O, Tousoulis D, Antoniades C, Badimon L, Bugiardini R, Chieffo A, et al. Sex and gender differences in coronary pathophysiology and ischaemic heart disease. Eur Heart J. 2026. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf1059.","journal-title":"Eur Heart J"},{"issue":"4","key":"952_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.20517\/mtod.2025.131","volume":"5","author":"M Jamalinia","year":"2025","unstructured":"Jamalinia M, Saeian S, Nikkhoo N, Nazerian A, Lankarani KB. Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions. Metab Target Organ Damage. 2025;5(4):60. https:\/\/doi.org\/10.20517\/mtod.2025.131.","journal-title":"Metab Target Organ Damage"},{"issue":"1","key":"952_CR12","doi-asserted-by":"publisher","DOI":"10.20517\/mtod.2025.193","volume":"6","author":"A Lonardo","year":"2026","unstructured":"Lonardo A, Jamalinia M, Weiskirchen R. Biological determinants and outcomes of sex discrepancies in MASLD. Metab Target Organ Damage. 2026;6(1):4. https:\/\/doi.org\/10.20517\/mtod.2025.193.","journal-title":"Metab Target Organ Damage"},{"issue":"4","key":"952_CR13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/ijtm4040052","volume":"4","author":"LC Taylor","year":"2024","unstructured":"Taylor LC, Arthur G, de Carvalho CM, Stec DE, Badmus OO. Contribution of sex differences to the development of cardiovascular disease in Metabolic-Associated Steatotic Liver Disease (MASLD). Int J Transl Med (Basel). 2024;4(4):782\u2013809. https:\/\/doi.org\/10.3390\/ijtm4040052.","journal-title":"Int J Transl Med (Basel)"},{"issue":"11","key":"952_CR14","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1111\/liv.16086","volume":"44","author":"AE Henney","year":"2024","unstructured":"Henney AE, Riley DR, Hydes TJ, Anson M, Ibarburu GH, Zhao SS, et al. Metabolic syndrome traits differentially and cumulatively influence micro- and macrovascular disease risk in patients with MASLD. Liver Int. 2024;44(11):3031\u201349. https:\/\/doi.org\/10.1111\/liv.16086.","journal-title":"Liver Int"},{"key":"952_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.120403","volume":"407","author":"JE Roeters van Lennep","year":"2025","unstructured":"Roeters van Lennep JE, \u00d6\u00f6rni K, Binder CJ, Kronenberg F, Mallat Z, Raggi P, et al. The essential role of sex and gender in atherosclerosis research: a statement from the Editorial Board of Atherosclerosis and Executive Committee of the European Atherosclerosis Society. Atherosclerosis. 2025;407:120403. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120403.","journal-title":"Atherosclerosis"},{"key":"952_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2025.1579885","author":"D Laban","year":"2025","unstructured":"Laban D, Kattan A, Ait-Abdellah L, Krishna H, Le Master E, Levitan I. Sex differences in features of atherosclerotic plaques as revealed by various imaging techniques: historical review. Front Physiol. 2025. https:\/\/doi.org\/10.3389\/fphys.2025.1579885.","journal-title":"Front Physiol"},{"issue":"4","key":"952_CR17","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70(4):1457\u201369. https:\/\/doi.org\/10.1002\/hep.30626.","journal-title":"Hepatology"},{"issue":"6","key":"952_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41569-024-01110-1","volume":"22","author":"K Grodecki","year":"2025","unstructured":"Grodecki K, Geers J, Kwiecinski J, Lin A, Slipczuk L, Slomka PJ, et al. Phenotyping atherosclerotic plaque and perivascular adipose tissue: signalling pathways and clinical biomarkers in atherosclerosis. Nat Rev Cardiol. 2025;22(6):443\u201355. https:\/\/doi.org\/10.1038\/s41569-024-01110-1.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"952_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/s2213-8587(24)00318-8","volume":"13","author":"N Stefan","year":"2025","unstructured":"Stefan N, Yki-J\u00e4rvinen H, Neuschwander-Tetri BA. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diabetes Endocrinol. 2025;13(2):134\u201348. https:\/\/doi.org\/10.1016\/s2213-8587(24)00318-8.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"952_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-025-00626-y","volume":"14","author":"PA Barbhuiya","year":"2025","unstructured":"Barbhuiya PA, Yoshitomi R, Pathak MP. Understanding the link between sterol regulatory element binding protein (SREBPs) and metabolic dysfunction associated steatotic liver disease (MASLD). Curr Obes Rep. 2025;14(1):36. https:\/\/doi.org\/10.1007\/s13679-025-00626-y.","journal-title":"Curr Obes Rep"},{"issue":"1","key":"952_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2024.101409","volume":"19","author":"KH Burks","year":"2025","unstructured":"Burks KH, Stitziel NO, Davidson NO. Molecular regulation and therapeutic targeting of VLDL production in cardiometabolic disease. Cell Mol Gastroenterol Hepatol. 2025;19(1):101409. https:\/\/doi.org\/10.1016\/j.jcmgh.2024.101409.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"952_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-3-030-56514-5_16","volume-title":"Therapeutic lipidology","author":"KC Maki","year":"2021","unstructured":"Maki KC, Benes L, Dicklin MR. Pathophysiology and management of dyslipidemias associated with insulin-resistant states. In: Davidson MH, Toth PP, Maki KC, editors. Therapeutic lipidology. Cham: Springer International Publishing; 2021. p. 307\u201322."},{"key":"952_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136148","author":"S Kartsoli","year":"2025","unstructured":"Kartsoli S, Kostara CE, Papathanasiou A, Tsimihodimos V, Bairaktari ET, Christodoulou DK. Altered HDL phospholipid and fatty acid profile in MASLD: a possible explanation for the increased CVD risk. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26136148.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"952_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.102459","volume":"15","author":"H Duan","year":"2025","unstructured":"Duan H, Gong M, Yuan G, Wang Z. Sex hormone: a potential target at treating female metabolic dysfunction-associated steatotic liver disease? J Clin Exp Hepatol. 2025;15(2):102459. https:\/\/doi.org\/10.1016\/j.jceh.2024.102459.","journal-title":"J Clin Exp Hepatol"},{"key":"952_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.maturitas.2022.08.001","volume":"166","author":"N Torosyan","year":"2022","unstructured":"Torosyan N, Visrodia P, Torbati T, Minissian MB, Shufelt CL. Dyslipidemia in midlife women: approach and considerations during the menopausal transition. Maturitas. 2022;166:14\u201320. https:\/\/doi.org\/10.1016\/j.maturitas.2022.08.001.","journal-title":"Maturitas"},{"key":"952_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.120495","volume":"409","author":"C Ratti","year":"2025","unstructured":"Ratti C, Malaguti M, Emanuele D, Bellasi A, Sanna G. Understanding MASLD - from molecular pathogenesis to cardiovascular risk: a concise review for the clinical cardiologist. Atherosclerosis. 2025;409:120495. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120495.","journal-title":"Atherosclerosis"},{"key":"952_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084351","author":"G Miceli","year":"2024","unstructured":"Miceli G, Basso MG, Pintus C, Pennacchio AR, Cocciola E, Cuffaro M, et al. Molecular pathways of vulnerable carotid plaques at risk of ischemic stroke: a narrative review. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25084351.","journal-title":"Int J Mol Sci"},{"key":"952_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1254114","volume":"10","author":"L Alonso-Herranz","year":"2023","unstructured":"Alonso-Herranz L, Albarr\u00e1n-Ju\u00e1rez J, Bentzon JF. Mechanisms of fibrous cap formation in atherosclerosis. Front Cardiovasc Med. 2023;10:1254114. https:\/\/doi.org\/10.3389\/fcvm.2023.1254114.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"952_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-23883-x","volume":"25","author":"J Zhang","year":"2025","unstructured":"Zhang J, Li L, Lin L, Wu Y, Hu L, Feng Z, et al. Prognostic value of FIB-4 and NFS for cardiovascular events in patients with and without NAFLD. BMC Public Health. 2025;25(1):2747. https:\/\/doi.org\/10.1186\/s12889-025-23883-x.","journal-title":"BMC Public Health"},{"key":"952_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1433857","volume":"12","author":"R Sandireddy","year":"2024","unstructured":"Sandireddy R, Sakthivel S, Gupta P, Behari J, Tripathi M, Singh BK. Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases. Front Cell Dev Biol. 2024;12:1433857. https:\/\/doi.org\/10.3389\/fcell.2024.1433857.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"952_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1210\/er.2001-0045","volume":"23","author":"KL Chambliss","year":"2002","unstructured":"Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev. 2002;23(5):665\u201386. https:\/\/doi.org\/10.1210\/er.2001-0045.","journal-title":"Endocr Rev"},{"key":"952_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.122742","author":"SL Liu","year":"2019","unstructured":"Liu SL, Bajpai A, Hawthorne EA, Bae Y, Castagnino P, Monslow J, et al. Cardiovascular protection in females linked to estrogen-dependent inhibition of arterial stiffening and macrophage MMP12. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.122742.","journal-title":"JCI Insight"},{"issue":"11","key":"952_CR33","doi-asserted-by":"publisher","first-page":"e3566","DOI":"10.1210\/clinem\/dgaf175","volume":"110","author":"SR El Khoudary","year":"2025","unstructured":"El Khoudary SR, Chen X, Qi M, Matthews KA, Karlamangla AS, Gold EB, et al. The relation between systemic inflammation and the menopause transition: the study of women\u2019s health across the nation. J Clin Endocrinol Metab. 2025;110(11):e3566\u201376. https:\/\/doi.org\/10.1210\/clinem\/dgaf175.","journal-title":"J Clin Endocrinol Metab"},{"key":"952_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1570565","volume":"16","author":"TJ Nowak","year":"2025","unstructured":"Nowak TJ, Muehlenbein MP. Toward understanding sexual immune dimorphism in humans. Front Immunol. 2025;16:1570565. https:\/\/doi.org\/10.3389\/fimmu.2025.1570565.","journal-title":"Front Immunol"},{"key":"952_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2025.1579885","volume":"16","author":"D Laban","year":"2025","unstructured":"Laban D, Kattan A, Ait-Abdellah L, Krishna H, Le Master E, Levitan I. Sex differences in features of atherosclerotic plaques as revealed by various imaging techniques: historical review. Front Physiol. 2025;16:1579885. https:\/\/doi.org\/10.3389\/fphys.2025.1579885.","journal-title":"Front Physiol"},{"key":"952_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015473","author":"H Yanai","year":"2023","unstructured":"Yanai H, Adachi H, Hakoshima M, Iida S, Katsuyama H. Metabolic-dysfunction-associated steatotic liver disease-its pathophysiology, association with atherosclerosis and cardiovascular disease, and treatments. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242015473.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"952_CR37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/s2213-8587(22)00076-6","volume":"10","author":"RE Nappi","year":"2022","unstructured":"Nappi RE, Chedraui P, Lambrinoudaki I, Simoncini T. Menopause: a cardiometabolic transition. Lancet Diabetes Endocrinol. 2022;10(6):442\u201356. https:\/\/doi.org\/10.1016\/s2213-8587(22)00076-6.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"952_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00022","volume":"7","author":"A Chait","year":"2020","unstructured":"Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:22. https:\/\/doi.org\/10.3389\/fcvm.2020.00022.","journal-title":"Front Cardiovasc Med"},{"issue":"25","key":"952_CR39","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1161\/cir.0000000000000912","volume":"142","author":"SR El Khoudary","year":"2020","unstructured":"El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020;142(25):e506\u201332. https:\/\/doi.org\/10.1161\/cir.0000000000000912.","journal-title":"Circulation"},{"issue":"1","key":"952_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-024-02181-9","volume":"27","author":"N Katsiki","year":"2025","unstructured":"Katsiki N, Kolovou G, Vrablik M. Metabolic dysfunction associated-steatotic liver disease (MASLD) and cardiovascular risk: embrace all facets of the disease. Curr Cardiol Rep. 2025;27(1):19. https:\/\/doi.org\/10.1007\/s11886-024-02181-9.","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"952_CR41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/hc0302.102570","volume":"105","author":"NJ Brown","year":"2002","unstructured":"Brown NJ, Abbas A, Byrne D, Schoenhard JA, Vaughan DE. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women. Circulation. 2002;105(3):304\u20139. https:\/\/doi.org\/10.1161\/hc0302.102570.","journal-title":"Circulation"},{"issue":"2","key":"952_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/mbc.0000000000001115","volume":"33","author":"J Wang","year":"2022","unstructured":"Wang J, Lim HY, Nandurkar H, Ho P. Age, sex and racial differences in fibrin formation and fibrinolysis within the healthy population. Blood Coagul Fibrinolysis. 2022;33(2):141\u20134. https:\/\/doi.org\/10.1097\/mbc.0000000000001115.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"952_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1528871","volume":"12","author":"S Costanzo","year":"2025","unstructured":"Costanzo S, de Laat B, Di Castelnuovo A, van der Vorm L, De Curtis A, Cerletti C, et al. Age- and sex-dependency of thrombin generation parameters in the general Italian population: the Moli-sani study. Front Cardiovasc Med. 2025;12:1528871. https:\/\/doi.org\/10.3389\/fcvm.2025.1528871.","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"952_CR44","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1210\/jc.2003-030698","volume":"88","author":"G Iacobellis","year":"2003","unstructured":"Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88(11):5163\u20138. https:\/\/doi.org\/10.1210\/jc.2003-030698.","journal-title":"J Clin Endocrinol Metab"},{"key":"952_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/biom15030324","author":"M Zisis","year":"2025","unstructured":"Zisis M, Chondrogianni ME, Androutsakos T, Rantos I, Oikonomou E, Chatzigeorgiou A, et al. Linking cardiovascular disease and metabolic dysfunction-associated steatotic liver disease (MASLD): the role of cardiometabolic drugs in MASLD treatment. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15030324.","journal-title":"Biomolecules"},{"key":"952_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169338","author":"H Li","year":"2022","unstructured":"Li H, Konja D, Wang L, Wang Y. Sex differences in adiposity and cardiovascular diseases. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23169338.","journal-title":"Int J Mol Sci"},{"issue":"36","key":"952_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000039499","volume":"103","author":"H Jain","year":"2024","unstructured":"Jain H, Pervez N, Dey D, Raza FA, Jain J, Ahmed M, et al. Non-alcoholic fatty liver disease is associated with coronary flow reserve impairment: a pilot meta-analysis. Medicine (Baltimore). 2024;103(36):e39499. https:\/\/doi.org\/10.1097\/md.0000000000039499.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"952_CR48","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s10554-022-02546-7","volume":"38","author":"AC Kwan","year":"2022","unstructured":"Kwan AC, Wei J, Lee BP, Luong E, Salto G, Nguyen TT, et al. Subclinical hepatic fibrosis is associated with coronary microvascular dysfunction by myocardial perfusion reserve index: a retrospective cohort study. Int J Cardiovasc Imaging. 2022;38(7):1579\u201386. https:\/\/doi.org\/10.1007\/s10554-022-02546-7.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"4","key":"952_CR49","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/circresaha.121.319892","volume":"130","author":"HR Reynolds","year":"2022","unstructured":"Reynolds HR, Bairey Merz CN, Berry C, Samuel R, Saw J, Smilowitz NR, et al. Coronary arterial function and disease in women with no obstructive coronary arteries. Circ Res. 2022;130(4):529\u201351. https:\/\/doi.org\/10.1161\/circresaha.121.319892.","journal-title":"Circ Res"},{"issue":"6","key":"952_CR50","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1210\/endrev\/bnaf018","volume":"46","author":"J Dong","year":"2025","unstructured":"Dong J, Dennis K, Venkatakrishnan R, Hodson L, Tomlinson JW. The impact of estrogen deficiency on liver metabolism: implications for hormone replacement therapy. Endocr Rev. 2025;46(6):790\u2013809. https:\/\/doi.org\/10.1210\/endrev\/bnaf018.","journal-title":"Endocr Rev"},{"issue":"1","key":"952_CR51","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1152\/japplphysiol.00120.2025","volume":"139","author":"S Lehti","year":"1985","unstructured":"Lehti S, Korhonen TM, Soliymani R, Ruhanen H, L\u00e4hteenm\u00e4ki EI, Palviainen M, et al. The lipidome and proteome of high-density lipoprotein are altered in menopause. J Appl Physiol. 1985;139(1):308\u201324. https:\/\/doi.org\/10.1152\/japplphysiol.00120.2025.","journal-title":"J Appl Physiol"},{"issue":"6","key":"952_CR52","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/cvr\/cvaf056","volume":"121","author":"C Janssen-Telders","year":"2025","unstructured":"Janssen-Telders C, Eringa EC, de Groot JR, de Man FS, Handoko ML. The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction. Cardiovasc Res. 2025;121(6):860\u201370. https:\/\/doi.org\/10.1093\/cvr\/cvaf056.","journal-title":"Cardiovasc Res"},{"key":"952_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms14020471","author":"J Zhou","year":"2026","unstructured":"Zhou J, Zhu B, Bing Z, Wang T, Zhao Y. The Gut-Liver Axis in MASLD: From Host-Microbiome Crosstalk to Precision Therapeutics. Microorganisms. 2026. https:\/\/doi.org\/10.3390\/microorganisms14020471.","journal-title":"Microorganisms"},{"key":"952_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1577724","volume":"16","author":"M Buchynskyi","year":"2025","unstructured":"Buchynskyi M, Kamyshna I, Halabitska I, Petakh P, Kunduzova O, Oksenych V, et al. Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease. Front Microbiol. 2025;16:1577724. https:\/\/doi.org\/10.3389\/fmicb.2025.1577724.","journal-title":"Front Microbiol"},{"issue":"1","key":"952_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11914-024-00896-w","volume":"23","author":"M Kverka","year":"2024","unstructured":"Kverka M, Stepan JJ. Associations among estrogens, the gut microbiome and osteoporosis. Curr Osteoporos Rep. 2024;23(1):2. https:\/\/doi.org\/10.1007\/s11914-024-00896-w.","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"952_CR56","doi-asserted-by":"publisher","first-page":"355","DOI":"10.20517\/jtgg.2024.70","volume":"8","author":"R Weiskirchen","year":"2024","unstructured":"Weiskirchen R, Lonardo A. PNPLA3 as a driver of steatotic liver disease: navigating from pathobiology to the clinics via epidemiology. J Transl Genet Genom. 2024;8(4):355\u201377. https:\/\/doi.org\/10.20517\/jtgg.2024.70.","journal-title":"J Transl Genet Genom"},{"issue":"1","key":"952_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/2042-6410-5-3","volume":"5","author":"S Sharma","year":"2014","unstructured":"Sharma S, Eghbali M. Influence of sex differences on microRNA gene regulation in disease. Biol Sex Differ. 2014;5(1):3. https:\/\/doi.org\/10.1186\/2042-6410-5-3.","journal-title":"Biol Sex Differ"},{"issue":"12","key":"952_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103428","volume":"24","author":"A Das","year":"2021","unstructured":"Das A, Basu S, Bandyopadhyay D, Mukherjee K, Datta D, Chakraborty S, et al. Inhibition of extracellular vesicle-associated MMP2 abrogates intercellular hepatic miR-122 transfer to liver macrophages and curtails inflammation. iScience. 2021;24(12):103428. https:\/\/doi.org\/10.1016\/j.isci.2021.103428.","journal-title":"iScience"},{"issue":"10","key":"952_CR59","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.tem.2023.07.003","volume":"34","author":"CB Wiese","year":"2023","unstructured":"Wiese CB, Avetisyan R, Reue K. The impact of chromosomal sex on cardiometabolic health and disease. Trends Endocrinol Metab. 2023;34(10):652\u201365. https:\/\/doi.org\/10.1016\/j.tem.2023.07.003.","journal-title":"Trends Endocrinol Metab"},{"key":"952_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2026.05.001","author":"M Jamalinia","year":"2026","unstructured":"Jamalinia M, Targher G, Lonardo A. X-chromosome gene dosage shapes MASLD beyond sex hormones. Trends Endocrinol Metab. 2026. https:\/\/doi.org\/10.1016\/j.tem.2026.05.001.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"952_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-023-00527-6","volume":"14","author":"MF Buono","year":"2023","unstructured":"Buono MF, Benavente ED, Daniels M, Mol BM, Mekke JM, de Borst GJ, et al. X chromosome inactivation skewing is common in advanced carotid atherosclerotic lesions in females and predicts secondary peripheral artery events. Biol Sex Differ. 2023;14(1):43. https:\/\/doi.org\/10.1186\/s13293-023-00527-6.","journal-title":"Biol Sex Differ"},{"issue":"3","key":"952_CR62","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/eurjpc\/zwaf224","volume":"33","author":"AE Spiering","year":"2026","unstructured":"Spiering AE, Groenheide PJ, Mokry M, Onland-Moret NC, Civelek M, Reue K, et al. Sex chromosomes and cardiovascular disease. Eur J Prev Cardiol. 2026;33(3):316\u201326. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf224.","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"952_CR63","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/apt.70457","volume":"63","author":"M Jamalinia","year":"2026","unstructured":"Jamalinia M, Zare F, Mantovani A, Targher G, Lonardo A. Meta-analysis: liver disease burden and associated factors in Turner syndrome. Aliment Pharmacol Ther. 2026;63(4):468\u201382. https:\/\/doi.org\/10.1111\/apt.70457.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"952_CR64","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s11033-025-10675-0","volume":"52","author":"H Fallah","year":"2025","unstructured":"Fallah H, Danesh B, Shahouzehi B. Combined effects of IRAK inhibition and pioglitazone on hepatic inflammation and apoptosis in a mouse model of MASLD. Mol Biol Rep. 2025;52(1):576. https:\/\/doi.org\/10.1007\/s11033-025-10675-0.","journal-title":"Mol Biol Rep"},{"issue":"10250","key":"952_CR65","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/s0140-6736(20)31561-0","volume":"396","author":"F Mauvais-Jarvis","year":"2020","unstructured":"Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396(10250):565\u201382. https:\/\/doi.org\/10.1016\/s0140-6736(20)31561-0.","journal-title":"Lancet"},{"issue":"2","key":"952_CR66","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ueg2.12370","volume":"11","author":"D Bizzaro","year":"2023","unstructured":"Bizzaro D, Becchetti C, Trapani S, Lavezzo B, Zanetto A, D\u2019Arcangelo F, et al. Influence of sex in alcohol-related liver disease: pre-clinical and clinical settings. United Eur Gastroenterol J. 2023;11(2):218\u201327. https:\/\/doi.org\/10.1002\/ueg2.12370.","journal-title":"United Eur Gastroenterol J"},{"key":"952_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1321319","volume":"11","author":"A Alcaraz","year":"2023","unstructured":"Alcaraz A, Lazo E, Casarini A, Rodriguez-Cairoli F, Augustovski F, Bardach A, et al. Exploring gender disparities in the disease and economic tobacco-attributable burden in Latin America. Front Public Health. 2023;11:1321319. https:\/\/doi.org\/10.3389\/fpubh.2023.1321319.","journal-title":"Front Public Health"},{"issue":"Suppl 3","key":"952_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-016-3706-5","volume":"16","author":"M Schlichthorst","year":"2016","unstructured":"Schlichthorst M, Sanci LA, Pirkis J, Spittal MJ, Hocking JS. Why do men go to the doctor? Socio-demographic and lifestyle factors associated with healthcare utilisation among a cohort of Australian men. BMC Public Health. 2016;16(Suppl 3):1028. https:\/\/doi.org\/10.1186\/s12889-016-3706-5.","journal-title":"BMC Public Health"},{"issue":"2","key":"952_CR69","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1093\/ejendo\/lvad170","volume":"190","author":"LM van Zijverden","year":"2024","unstructured":"van Zijverden LM, Wiepjes CM, van Diemen JJK, Thijs A, den Heijer M. Cardiovascular disease in transgender people: a systematic review and meta-analysis. Eur J Endocrinol. 2024;190(2):S13-s24. https:\/\/doi.org\/10.1093\/ejendo\/lvad170.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"952_CR70","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1089\/trgh.2022.0182","volume":"9","author":"JE Lake","year":"2024","unstructured":"Lake JE, Hyatt AN, Feng H, Miao H, Somasunderam A, Utay NS, et al. Transgender women with HIV demonstrate unique non-alcoholic fatty liver disease profiles. Transgend Health. 2024;9(5):413\u201320. https:\/\/doi.org\/10.1089\/trgh.2022.0182.","journal-title":"Transgend Health"},{"issue":"1","key":"952_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57894-y","volume":"10","author":"SH Kim","year":"2020","unstructured":"Kim SH, Park HY, Lee HS, Jung KS, Lee MH, Jhee JH, et al. Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity. Sci Rep. 2020;10(1):1025. https:\/\/doi.org\/10.1038\/s41598-020-57894-y.","journal-title":"Sci Rep"},{"issue":"4","key":"952_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2026.104579","volume":"36","author":"M Jamalinia","year":"2026","unstructured":"Jamalinia M, Targher G, Lonardo A, Heydari ST, Bagheri Lankarani K. Application of machine learning for sex-specific risk prediction of coronary artery calcification. Nutr Metab Cardiovasc Dis. 2026;36(4):104579. https:\/\/doi.org\/10.1016\/j.numecd.2026.104579.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"952_CR73","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/gme.0000000000000503","volume":"22","author":"MK Kim","year":"2015","unstructured":"Kim MK, Ahn CW, Nam JS, Kang S, Park JS, Kim KR. Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women. Menopause. 2015;22(12):1323\u20137. https:\/\/doi.org\/10.1097\/gme.0000000000000503.","journal-title":"Menopause"},{"issue":"2","key":"952_CR74","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jhep.2015.02.045","volume":"63","author":"JL Mellinger","year":"2015","unstructured":"Mellinger JL, Pencina KM, Massaro JM, Hoffmann U, Seshadri S, Fox CS, et al. Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham heart study. J Hepatol. 2015;63(2):470\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.045.","journal-title":"J Hepatol"},{"key":"952_CR75","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.atherosclerosis.2016.11.021","volume":"258","author":"RA Remigio-Baker","year":"2017","unstructured":"Remigio-Baker RA, Allison MA, Forbang NI, Loomba R, Anderson CAM, Budoff M, et al. Race\/ethnic and sex disparities in the non-alcoholic fatty liver disease-abdominal aortic calcification association: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2017;258:89\u201396. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.11.021.","journal-title":"Atherosclerosis"},{"issue":"12","key":"952_CR76","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1507\/endocrj.ej13-0269","volume":"60","author":"KS Kim","year":"2013","unstructured":"Kim KS, Oh HJ, Kim DJ, Kim SK, Park SW, Cho YW, et al. The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels. Endocr J. 2013;60(12):1295\u2013301. https:\/\/doi.org\/10.1507\/endocrj.ej13-0269.","journal-title":"Endocr J"},{"issue":"5","key":"952_CR77","first-page":"407","volume":"66","author":"R Mart\u00ednez-Alvarado Mdel","year":"2014","unstructured":"Mart\u00ednez-Alvarado Mdel R, Ju\u00e1rez-Rojas JG, Medina-Urrutia AX, Cardoso-Salda\u00f1a GC, Gonz\u00e1lez-Salazar Mdel C, Posadas-S\u00e1nchez R, et al. Association of fatty liver with cardiovascular risk factors and subclinical atherosclerosis in a Mexican population. Rev Invest Clin. 2014;66(5):407\u201314.","journal-title":"Rev Invest Clin"},{"issue":"5","key":"952_CR78","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5830\/cvja-2016-014","volume":"27","author":"HJ Kim","year":"2016","unstructured":"Kim HJ, Lim CW, Lee JH, Park HB, Suh Y, Cho YH, et al. Gender-based differences in the relationship between fatty liver disease and atherosclerosis. Cardiovasc J Afr. 2016;27(5):281\u20136. https:\/\/doi.org\/10.5830\/cvja-2016-014.","journal-title":"Cardiovasc J Afr"},{"issue":"6","key":"952_CR79","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1097\/hjh.0000000000001285","volume":"35","author":"X Li","year":"2017","unstructured":"Li X, Shi H, Wang Z, Chang L, Zhang M, Dong X. Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease. J Hypertens. 2017;35(6):1226\u201334. https:\/\/doi.org\/10.1097\/hjh.0000000000001285.","journal-title":"J Hypertens"},{"issue":"7","key":"952_CR80","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.numecd.2024.03.008","volume":"34","author":"TK Yoo","year":"2024","unstructured":"Yoo TK, Lee SW, Lee MY, Choi H, Sung KC. Influence of MAFLD and NAFLD on arterial stiffness: a longitudinal cohort study. Nutr Metab Cardiovasc Dis. 2024;34(7):1769\u201378. https:\/\/doi.org\/10.1016\/j.numecd.2024.03.008.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"41","key":"952_CR81","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1093\/eurheartj\/ehy534","volume":"39","author":"LJ Shaw","year":"2018","unstructured":"Shaw LJ, Min JK, Nasir K, Xie JX, Berman DS, Miedema MD, et al. Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium. Eur Heart J. 2018;39(41):3727\u201335. https:\/\/doi.org\/10.1093\/eurheartj\/ehy534.","journal-title":"Eur Heart J"},{"key":"952_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/life15081288","author":"BB M\u00e1ty\u00e1s","year":"2025","unstructured":"M\u00e1ty\u00e1s BB, Benedek I, Rat N, Bl\u00eendu E, Rodean IP, Haja I, et al. Assessment of the association between coronary artery calcification, plaque vulnerability, and perivascular inflammation via coronary CT angiography. Life. 2025. https:\/\/doi.org\/10.3390\/life15081288.","journal-title":"Life"},{"key":"952_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1021023","volume":"10","author":"P Baru\u015b","year":"2023","unstructured":"Baru\u015b P, Piasecki A, Gumi\u0119\u017cna K, Bednarek A, Dunaj P, G\u0142\u00f3d M, et al. Multimodality OCT, IVUS and FFR evaluation of coronary intermediate grade lesions in women vs. men. Front Cardiovasc Med. 2023;10:1021023. https:\/\/doi.org\/10.3389\/fcvm.2023.1021023.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"952_CR84","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s10554-022-02775-w","volume":"39","author":"FG Biccir\u00e8","year":"2023","unstructured":"Biccir\u00e8 FG, Debelak C, Varricchione G, Budassi S, Gatto L, Romagnoli E, et al. Sex-specific features of optical coherence tomography detected plaque vulnerability related to clinical outcomes: insights from the CLIMA study. Int J Cardiovasc Imaging. 2023;39(4):873\u201381. https:\/\/doi.org\/10.1007\/s10554-022-02775-w.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"12","key":"952_CR85","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1016\/j.jcmg.2020.07.008","volume":"13","author":"TA Fairbairn","year":"2020","unstructured":"Fairbairn TA, Dobson R, Hurwitz-Koweek L, Matsuo H, Norgaard BL, R\u00f8nnow Sand NP, et al. Sex differences in coronary computed tomography angiography-derived fractional flow reserve: lessons from ADVANCE. JACC Cardiovasc Imaging. 2020;13(12):2576\u201387. https:\/\/doi.org\/10.1016\/j.jcmg.2020.07.008.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"952_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17875-9","volume":"12","author":"M Al Rifai","year":"2022","unstructured":"Al Rifai M, Ahmed AI, Han Y, Saad JM, Alnabelsi T, Nabi F, et al. Sex differences in machine learning computed tomography-derived fractional flow reserve. Sci Rep. 2022;12(1):13861. https:\/\/doi.org\/10.1038\/s41598-022-17875-9.","journal-title":"Sci Rep"},{"issue":"22","key":"952_CR87","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.124.039496","volume":"14","author":"K Ikeda","year":"2025","unstructured":"Ikeda K, Munhoz D, Brouwers S, Sonck J, Matsuo H, Shinke T, et al. Sex differences in atherosclerotic coronary artery disease patterns. J Am Heart Assoc. 2025;14(22):e039496. https:\/\/doi.org\/10.1161\/jaha.124.039496.","journal-title":"J Am Heart Assoc"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-026-00952-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-026-00952-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-026-00952-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:19:12Z","timestamp":1790813952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13293-026-00952-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1186\/s13293-026-00952-3","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"162"}}